Polyphenols and Longevity: Why They Are Getting More Attention

Polyphenols and Longevity: Why They Are Getting More Attention

Polyphenols are plant compounds, found in foods like grapes, berries and green tea, that have drawn increasing research attention because several of them activate biological pathways linked to cellular maintenance and stress resistance, particularly a pathway involving sirtuin enzymes. The two most studied in the longevity space are resveratrol and pterostilbene, close chemical relatives with a similar mechanism but a genuinely different practical profile: resveratrol has the deeper human trial history, while pterostilbene has meaningfully better absorption in the body. That absorption difference matters more than most polyphenol marketing lets on.

Polyphenols have gone from a footnote in nutrition science, the reason red wine and berries got a health halo, to a genuine focus of longevity research over the past two decades. As the scientific community delves deeper into polyphenols ageing research, understanding how these natural molecules interact with our biological systems has become paramount for those tracking advancements in healthspan and lifespan extension.

The attention isn't unfounded. Certain polyphenols engage biological pathways that researchers have connected to several recognised hallmarks of ageing, including oxidative stress, inflammation and cellular senescence. But the research is also more layered than "eat more polyphenols, live longer," particularly once you look at how well these compounds actually get absorbed and used by the body.

Why Polyphenols Have Become Such an Important Research Topic

A 2018 review in the journal BioFactors examined resveratrol and pterostilbene specifically and found that both compounds influence a cluster of biological processes tied to ageing, including activating SIRT1, an enzyme in the same sirtuin family involved in NAD+ biology, inhibiting the inflammatory NF-κB pathway, and modulating autophagy, the cellular clean-up process. The same review notes both compounds show effects on oxidative damage, inflammation, telomere attrition and cellular senescence across the studies examined.

This breadth is exactly why polyphenols keep showing up across so many different areas of longevity research, they intersect with several of the same pathways researchers already care about for other reasons. When looking at cellular health, maintaining mitochondrial function and mitigating the impacts of oxidative stress are critical components of healthy ageing. Polyphenols act as powerful antioxidants, scavenging free radicals while simultaneously upregulating endogenous defence mechanisms.

Understanding What Polyphenols Actually Do in Simple Terms

Think of these compounds less as a direct repair tool and more as a signal that tells cells to activate their own existing maintenance and defence systems.

Rather than supplying a missing nutrient, resveratrol and pterostilbene appear to nudge cells into a mild, protective stress response, similar in concept to how a small amount of exercise-induced stress triggers beneficial adaptations. This is a genuinely different mode of action to a vitamin correcting a deficiency, which is part of why the effects are subtler and harder to measure in short human trials than a straightforward nutrient repletion study would be. Through this hormetic signaling, sirtuins are stimulated, promoting crucial processes like autophagy and protecting mitochondrial function against age-related decline.

The Bioavailability Problem Nobody Mentions

This is the part of the polyphenol story that gets skipped over most often, and it matters enormously.

A now-classic human pharmacokinetic study found that while oral resveratrol is well absorbed, at least 70 per cent, its systemic bioavailability is very low, because it is extremely rapidly broken down by sulfate conjugation in the intestine and liver, leaving only trace amounts of the unmodified compound in the bloodstream. In practice, this means a meaningful proportion of the resveratrol in a typical supplement dose may never reach cells in its active form. Pterostilbene, a close structural relative of resveratrol with two methoxy groups instead of hydroxyl groups, shows improved membrane permeability and a longer half-life in the body, which is a major part of why formulators increasingly favour it over resveratrol despite resveratrol having the longer research history.

For individuals exploring different formulations available through specialised providers like Do Not Age, Elysium Health, or ProHealth Longevity, understanding these pharmacokinetic hurdles helps clarify why chemical modifications or alternative analogues are frequently chosen over generic plant extracts.

What the Human Trials Actually Show

Human data on resveratrol specifically is more developed than pterostilbene's, and it's honestly mixed but genuinely interesting.

A small, well-controlled crossover trial published in Cell Metabolism gave 11 obese but otherwise healthy men 150mg of resveratrol daily for 30 days and found it activated AMPK and increased SIRT1 and PGC-1α levels in muscle tissue, alongside reduced resting metabolic rate, reduced blood glucose and improved markers of liver fat, broadly mimicking several effects associated with calorie restriction. This is a genuinely notable result, but it's also a small trial, 11 participants, over a relatively short 30-day period, which is why researchers describe this as an interesting signal worth building on rather than a settled clinical outcome.

Why NovusDNA Uses Pterostilbene Specifically

Given the bioavailability issue outlined above, NovusDNA's Longevity+ includes pterostilbene rather than resveratrol, alongside nicotinamide riboside (NR-CL), TMG and piperine.

This isn't a marketing preference, it follows directly from the pharmacokinetic research: a compound that reaches cells more reliably is a more defensible formulation choice than one with a well-documented absorption problem, even if that second compound has a longer research history. NovusDNA doesn't claim pterostilbene reverses ageing or replicates calorie restriction in humans. It's included as nutritional support for cellular stress-response pathways, framed at the level the current evidence actually supports.

How Researchers Continue to Study This

Beyond metabolic effects, researchers are increasingly interested in polyphenols as potential senotherapeutics, compounds capable of influencing senescent cell behaviour, building on preclinical evidence that resveratrol and pterostilbene can reduce inflammatory signalling associated with cellular senescence in laboratory models. This work remains largely preclinical, and researchers studying it are explicit that clinical validation in humans, particularly around long-term safety and effective dosing, is still needed before any therapeutic claims would be appropriate.


FAQ

What exactly are polyphenols, and why does longevity research focus on them? 

Polyphenols are naturally occurring plant compounds found in foods like grapes, berries, green tea and peanuts. Longevity researchers focus on a specific subset, particularly resveratrol and pterostilbene, because they appear to activate SIRT1 and related pathways connected to several recognised hallmarks of ageing, including oxidative stress, inflammation and cellular senescence, based on a body of preclinical and some human research. They're of interest because of this shared mechanism, not because polyphenols in general have been shown to extend human lifespan.

Is resveratrol actually absorbed well when you take it as a supplement? 

It's absorbed into the gut reasonably well, but very little of it survives in its active form afterwards. A landmark human study found that although oral resveratrol showed high initial absorption, it undergoes extremely rapid metabolism in the intestine and liver, meaning only trace amounts of the unmodified compound reach the bloodstream. This bioavailability limitation is one of the most consistently reported issues in resveratrol research and is a major reason some formulations use structurally similar compounds like pterostilbene instead.

Why does NovusDNA use pterostilbene instead of resveratrol in Longevity+? 

Pterostilbene shares much of resveratrol's proposed mechanism but has better membrane permeability and a longer half-life in the body, addressing the bioavailability problem that limits resveratrol's practical effectiveness. NovusDNA includes it as nutritional support for cellular stress-response pathways rather than positioning it as a proven anti-ageing treatment, since human clinical data specifically on pterostilbene remains more limited than the early human data available for resveratrol.

Do polyphenol supplements actually slow ageing in humans? 

This hasn't been demonstrated. The most notable human data, a small 30-day trial of resveratrol in obese men, showed genuine metabolic changes resembling some effects of calorie restriction, including improved markers of blood glucose and liver fat, but the trial involved only 11 participants and didn't measure ageing or lifespan directly. Preclinical research into polyphenols and cellular senescence is ongoing but has not yet been validated in human clinical trials, so current evidence supports interest and investigation, not a proven anti-ageing effect.

Polyphenols are getting more research attention because the underlying mechanism, particularly SIRT1 activation and effects on oxidative stress and senescence, genuinely intersects with several hallmarks of ageing researchers already take seriously. The catch that often gets left out of the marketing is bioavailability: resveratrol's poor absorption is well documented, which is a large part of why NovusDNA formulates Longevity+ with pterostilbene instead, backed by the same pharmacokinetic reasoning rather than a preference for a newer ingredient name.